Clinical Trial Services

From India, to the world, Sristek has always believed in one philosophy- Global Reach with Local Expertise. With strong experience of conducting clinical trials in regions like US, Western and Eastern Europe, Asia-Pacific etc, Sristek has the global reach and capability to conduct studies and navigate regulatory requirements of IND, ANDA, WHO and various Local regulatory agencies. Backed by strong clinical and therapeutic expertise, we take a highly flexible and customized approach to clinical research by listening closely to our customers and tailoring our services to their unique needs and projects, from select stand-alone services to full-service international studies.

A snapshot of our clinical trial projects by therapeutic areas is mentioned below:

Sristek's Therapeutic Experience
Therapeutic Area Phase I Phase II Phase III Phase IV
Diabetics      
Anti-infective      
Opthalmology      
Vaccine
Dermatology      
Neurology      
Psychiatry      
Medical Device    
Oncology    
Gynecology      
Gastroenterology      

Details of each study as are follows:

Diabetics

Description Indication No. of Sites Patients Geographical Coverage Service Provided
Phase III Type II Diabetes Mellitus 12 201 India Full service
Phase III Type II Diabetes Mellitus 6 96 India Full service

Infectious Diseases:

Description Indication No. of Sites Patients Geographical Coverage Service Provided
Phase III Urinary Tract Infection 2 200 India Full service

Ophthalmology:

Description Indication No. of Sites Patients Geographical Coverage Service Provided
Phase IV Allegic Conjunctivitis 20 300 India Full Service
Phase IV Dry Eye 20 300 India Full Service
Phase I Wet AMD & Diabetic Retinopathy 1 50 Bangladesh Full Service

Immunology:

Description Indication No. of Sites Patients Geographical Coverage Service Provided
Phase III Measles 9 600 India Full service
Phase III DTP 8 306 India Full service
Phase III DT 3 100 India Full service
Phase III Tetanus 5 600 India Full service
Phase III Tetanus 1 120 India Full service
Phase IV DTP-Hb-H1b 40 640 India Full service
Phase II/III Japanese Encephalitis 8 456 India Full service
Phase II/III DTPH 1 33 India Full service
Phase I Measles 1 180 India Clinical Operations & Vendor management
Phase I Swine Flu 3 100 India Clinical Operations
Phase I Meningococcal 3 100 India Full Service
Phase III Varicella 4 100 India Full service

Dermatology:

Description Indication No. of Sites Patients Geographical Coverage Service Provided
Phase III Psoriasis 15 600 India Full Service
Phase III Rosacea 10 450 India Full Service

Neurology

Description Indication No. of Sites Patients Geographical Coverage Service Provided
Phase IIb Acute Ischemic Stroke 10 90 India Full Service
Phase II Parkinson's disease 7 60 India Full Service

Psychiatry:

Description Indication No. of Sites Patients Geographical Coverage Service Provided
Phase II Schizophrenia 19 228 India, US, Philippines and Malaysia Full Service

Medical Devices:

Description Indication No. of Sites Patients Geographical Coverage Service Provided
Phase II Venous leg ulcer 4 40 India Full Service
Phase III Venous leg ulcer 5 25 India Full Service
Phase III Venous leg ulcer 9 100 India Full Service

Oncology:

Description Indication No. of Sites Patients Geographical Coverage Service Provided
Phase IV Non small cell lung cancer 4 19 India Full service
Phase IV Early Breast Cancer 4 13 India Full service
Phase IV Metastatic Colorectal Cancer 3 16 India Full service

Gynecology:

Description Indication No. of Sites Patients Geographical Coverage Service Provided
Phase III Dysmenorrhea 14 480 India Full Service

Gastroenterology:

Description Indication No. of Sites Patients Geographical Coverage Service Provided
Phase III Duodenal ulcer 30 600 India Full Service